Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-In Capital	[1]	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023	[1]		1,695,788
Beginning balance at Dec. 31, 2023		$ 26,768	$ 2	[1]	$ 192,029		$ (165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with at-the-market offering (net of issuance costs), shares	[1]		4,329
Issuance of common stock in connection with at-the-market offering (net of issuance costs)		253			253
Stock-based compensation		1,318			1,318
Issuance of common stock under equity plan awards (in shares)	[1]		8,901
Issuance of common stock under equity plan award		197			197
Net loss		(7,904)					(7,904)
Ending balance (in shares) at Mar. 31, 2024	[1]		1,709,018
Ending balance at Mar. 31, 2024		20,632	$ 2	[1]	193,797		(173,167)
Beginning balance (in shares) at Dec. 31, 2023	[1]		1,695,788
Beginning balance at Dec. 31, 2023		26,768	$ 2	[1]	192,029		(165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(17,474)
Ending balance (in shares) at Jun. 30, 2024	[1]		1,882,751
Ending balance at Jun. 30, 2024		16,939	$ 2	[1]	199,674		(182,737)
Beginning balance (in shares) at Mar. 31, 2024	[1]		1,709,018
Beginning balance at Mar. 31, 2024		20,632	$ 2	[1]	193,797		(173,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with at-the-market offering (net of issuance costs), shares	[1]		164,118
Issuance of common stock in connection with at-the-market offering (net of issuance costs)		4,557	$ 0	[1]	4,557
Stock-based compensation		1,320			1,320
Issuance of common stock under equity plan awards (in shares)	[1]		9,615
Net loss		(9,570)					(9,570)
Ending balance (in shares) at Jun. 30, 2024	[1]		1,882,751
Ending balance at Jun. 30, 2024		16,939	$ 2	[1]	199,674		(182,737)
Beginning balance (in shares) at Dec. 31, 2024	[1]		3,382,432
Beginning balance at Dec. 31, 2024		19,126	$ 3	[1]	226,229		(207,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with at-the-market offering (net of issuance costs), shares	[1]		133,521
Issuance of common stock in connection with at-the-market offering (net of issuance costs)		1,444	$ 1	[1]	1,443
Stock-based compensation		1,389			1,389
Issuance of common stock under equity plan awards (in shares)	[1]		3,649
Issuance of common stock under equity plan award		34			34
Net loss		(10,860)					(10,860)
Ending balance (in shares) at Mar. 31, 2025	[1]		3,519,602
Ending balance at Mar. 31, 2025		11,133	$ 4	[1]	229,095		(217,966)
Beginning balance (in shares) at Dec. 31, 2024	[1]		3,382,432
Beginning balance at Dec. 31, 2024		19,126	$ 3	[1]	226,229		(207,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(18,730)
Ending balance (in shares) at Jun. 30, 2025	[1]		4,437,855
Ending balance at Jun. 30, 2025		9,783	$ 4	[1]	235,615		(225,836)
Beginning balance (in shares) at Mar. 31, 2025	[1]		3,519,602
Beginning balance at Mar. 31, 2025		11,133	$ 4	[1]	229,095		(217,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance cost (in shares)	[1]		584,253
Issuance of common stock for cash, net of issuance cost		3,570			3,570
Stock-based compensation		1,092			1,092
Issuance of pre-funded warrants, (net of issuance costs), in shares	[1]		334,000
Issuance of pre-funded warrants, (net of issuance costs)		1,858			1,858
Net loss		(7,870)					(7,870)
Ending balance (in shares) at Jun. 30, 2025	[1]		4,437,855
Ending balance at Jun. 30, 2025		$ 9,783	$ 4	[1]	$ 235,615		$ (225,836)

[1] Shares issued and outstanding have been adjusted to reflect the one-for-thirteen stock split effected in April 2025. See Note 1, Organization and Description of the Business, for details.